Reduction of cortical amyloid β levels in guinea pig brain after systemic administration of physostigmine
- 21 August 2001
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 310 (1) , 21-24
- https://doi.org/10.1016/s0304-3940(01)02076-6
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Comparative Analysis of Amyloid-β Chemical Structure and Amyloid Plaque Morphology of Transgenic Mouse and Alzheimer's Disease BrainsJournal of Biological Chemistry, 2001
- The selective muscarinic M1 agonist AF102B decreases levels of total A? in cerebrospinal fluid of patients with Alzheimer's diseaseAnnals of Neurology, 2000
- DonepezilDrugs & Aging, 2000
- Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's DiseaseThe American Journal of Pathology, 1999
- The Levels of Soluble versus Insoluble Brain Aβ Distinguish Alzheimer's Disease from Normal and Pathologic AgingExperimental Neurology, 1999
- Muscarinic m1 receptor agonists increase the secretion of the amyloid precursor protein ectodomainLife Sciences, 1997
- The muscarinic M1 agonist xanomeline increases soluble amyloid precursor protein release from chinese hamster ovary-m1 cellsLife Sciences, 1995
- Cholinesterase inhibitors increase secretion of APPs in rat brain cortexNeuroReport, 1995
- Muscarinic Regulation of Alzheimer's Disease Amyloid Precursor Protein Secretion and Amyloid β-Protein Production in Human Neuronal NT2N CellsJournal of Biological Chemistry, 1995
- Release of Alzheimer Amyloid Precursor Derivatives Stimulated by Activation of Muscarinic Acetylcholine ReceptorsScience, 1992